Save on XALATAN and receive the Xal-Ease™ applicator when you Sign Up for Vision Matters™
Tools
Being diagnosed with high eye pressure can be scary. But high eye pressure can be treated. XALATAN is your partner in the fight against high eye pressure which can lead to glaucoma.
These tools help make it even easier to learn about and manage your condition:
Xal-Ease™
Instructions for using Xal-Ease, a tool that may help you use your eyedrops more easily and with less waste. Xal-Ease is available for free when you join the Vision Matters™ program, or call 1-866-846-9005
Appointment Questionnaire
Take this questionnaire to your next doctor's appointment. It will help you have a productive discussion with your doctor about your eye health
Eye Pressure Tracker
Use this helpful chart to keep track of your medication and progress
Glaucoma Simulator
The glaucoma simulator shows how glaucoma can progress and affect your eyesight
Video Library
Videos about glaucoma, XALATAN, and more
Information Resources
Sources of additional information about eye health, including high eye pressure and glaucoma
Next: Xal-Ease™
Save on XALATAN
Find out how you may be able to save on your XALATAN prescriptions. Learn more
Talking With Your Doctor
Learn how to talk to your eye doctor about high eye pressure and XALATAN. Get it now
Indication
XALATAN is for the treatment of high eye pressure/intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension.
Important Safety Information
Like all medicines, XALATAN can have side effects. These side effects are usually mild and tolerable and may include blurred vision, burning and stinging, eye redness, the feeling of something in the eye, eye itching, increased pigmentation (darkening) of eye color, or irritation of the clear front surface of the eye.
XALATAN may slowly cause darkening of the eye color due to increased brown color, darkening of the eyelid and eyelashes, and increased growth and thickness of eyelashes. Color changes can increase as long as XALATAN is administered and eye color changes are likely to be permanent.
The recommended dosage is one drop (1.5 µg) in the affected eye(s) once daily in the evening. If one dose is missed, treatment should continue with the next dose as normal.
There have been reports of bacterial keratitis associated with the use of multiple-dose containers of topical ophthalmic products.
The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.
The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a health care provider. All decisions regarding patient care must be made with a health care provider, considering the unique characteristics of the patient.
Pfizer is a licensee of the TRUSTe Privacy Program.© 2010 Pfizer Inc. All rights reserved.
XLU00691F